Related Experiment Videos
Left ventricular muscle mass regression after aortic valve replacement.
1Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan, Seoul, Korea. jwlee@www.amc.seoul.kr
Journal of Korean Medical Science
|November 27, 1999
Summary
The 19 mm St. Jude Medical valve may not adequately reduce left ventricular mass in aortic stenosis patients. Larger valve sizes are recommended for better left ventricular hypertrophy regression.
Area of Science:
- Cardiology
- Cardiac Surgery
- Biomedical Engineering
Background:
- Aortic stenosis necessitates valve implantation to reduce left ventricular mass.
- Left ventricular hypertrophy (LVH) is a critical concern in aortic stenosis management.
Purpose of the Study:
- To assess left ventricular mass regression after aortic valve replacement (AVR) using St. Jude Medical (SJM) valves of varying sizes.
- To evaluate the impact of SJM valve size on the regression of left ventricular hypertrophy.
Main Methods:
- Serial electrocardiographic (ECG) and echocardiographic studies were performed on 46 AVR patients.
- Patients were stratified into three groups based on SJM valve size: 19 mm, 21 mm, and 23+ mm.
- Left ventricular muscle mass index (LVMI) and ECG voltage were analyzed preoperatively and postoperatively.
Main Results:
- No surgical mortality was observed.
- NYHA functional class improved significantly across all groups post-AVR.
- LVMI regression was statistically insignificant in the 19 mm SJM valve group, but significant in the 21 mm and 23+ mm groups.
- ECG voltage showed no significant differences among the valve size groups.
Conclusions:
- The 19 mm SJM valve may be insufficient for satisfactory left ventricular muscle mass regression in aortic stenosis patients.
- Larger valve sizes (≥21 mm) promote better LVMI regression.
- Consideration of additional procedures to implant larger valves may be beneficial for patients with smaller aortic annuli (<21 mm).